The United States recently secured 1.7 million doses of a compound that could help to treat COVID-19 patients. In preliminary studies, Molnupiravir reduced the transmission of the SARS-CoV-2 coronavirus. Researchers at the ...
Aug 16, 2021
0
1070
Researchers at the University of Southampton have gained unprecedented new insight into the key properties of an antibody needed to fight off cancer.
Jul 8, 2022
0
62
It's completely invisible, but the distinctive smell of electrical discharge after photocopying is a tell-tale sign of ozone in the air. Ozone is a component of what we refer to as 'smog' and on hot sunny days, in cities ...
Sep 7, 2015
0
86
Roller coasters may seem like a very modern type of entertainment – constantly getting bigger, faster and scarier thanks to advances in technology. But they actually date back to the mid-1800s. Gravity-propelled railways ...
Jul 11, 2018
0
5
Scientists at the Francis Crick Institute, UCL and the University of Edinburgh have uncovered how a build-up of harmful protein starts to happen within neurons in Parkinson's disease, ultimately causing nerve cell death. ...
Aug 30, 2022
0
133
The study, published recently in Circulation Research and led by a team from King's College London, has investigated how nitrogen dioxide can impact the cardiovascular system.
Jun 26, 2020
0
9
In a series of experiments using human cancer cell lines, scientists at Johns Hopkins Medicine say they have successfully used light as a trigger to make precise cuts in genomic material rapidly, using a molecular scalpel ...
Jun 17, 2020
0
37
For the 280 million people suffering from depression globally, relief cannot come fast enough. Monoaminergic antidepressants, including selective serotonin reuptake inhibitors (SSRIs) take weeks to months to take effect and ...
May 25, 2022
0
11
(Medical Xpress)—A new study in a mouse model has shown that neuropsychiatric disorders in adults were more likely to develop if the mice had suffered immune challenges before birth and stresses after birth. The study also ...
Imatinib, better known as Gleevec, was hailed as a "miracle" cancer drug when it entered the market in the early 2000s. Though it has been highly successful at treating early-stage chronic myeloid leukemia (CML)—a rare ...
Jun 1, 2022
0
150
